Comparison of 2 line blot assays for defining HPV genotypes in oral and oropharyngeal squamous cell carcinomas

Diagnostic Microbiology and Infectious Disease

Volumn 70, Issue 2, 2011, Pages 240-245

  Shanesmith, Rebecca ^a   Allen, Richard A ^a   Moore, William E ^c   Kingma, Douglas W ^a   Caughron, Samuel K ^b   Gillies, Elizabeth M ^a   Dunn, Samuel T ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b Yellowstone Pathology Institute Inc   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

HPV; Human papillomavirus; Line blot assay; Oral cavity; Oropharynx; Squamous cell carcinoma

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MOUTH CARCINOMA; ORAL SQUAMOUS CELL CARCINOMA; OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; OROPHARYNX CARCINOMA; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; REVERSE LINE BLOT ASSAY; SMOKING; SQUAMOUS CELL CARCINOMA; TONSIL; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; VIRUS DETECTION; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, SQUAMOUS CELL; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MIDDLE AGED; MOLECULAR TYPING; MOUTH NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PARAFFIN EMBEDDING; PHARYNGEAL NEOPLASMS; TOBACCO; VIROLOGY;

EID: 79955966564     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2011.01.011     Document Type: Article

References (23)

1. Ang K.K., Harris J., Wheeler R., Weber R., Rosental D.I., Nguyen-Tân P.F., Westra W.H., Chung C.H., Jordan R.C., Lu C., Kim H., Axelrod R., Silverman C.C., Redmond K.P., Gillison M.L. Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med. 2010, 363:24-35.
2. Castle P.E., Porras C., Quint W.G., Rodriguez A.C., Schiffman M., Gravitt P.E., González P., Katki H.A., Silva S., Freer E., Van Doorn L.J., Jiménez S., Herrero R., Hildesheim A. Comparison of two PCR-based human papillomavirus genotyping methods. J. Clin. Microbiol. 2008, 46:3437-3445. CVT Group.
3. D'Souza G., Kreimer A.R., Viscidi R., Pawlita M., Fakhry C., Koch W.M., Westra W.H., Gillison M.L. Case-control study of human papillomavirus and oropharyngeal cancer. N. Engl. J. Med. 2007, 356:1944-1956.
4. Dunn S.T., Allen R.A., Wang S., Walker J., Schiffman M. DNA extraction: an understudied and important aspect of HPV genotyping using PCR-based methods. J. Virol. Methods 2007, 143:45-54.
5. Fakhry C., Westra W.H., Li S., Cmelak A., Ridge J.A., Pinto H., Forastiere A., Gillison M.L. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J. Natl. Cancer Inst. 2008, 100:261-269.
6. Gillison M.L., D'Souza G., Westra W., Sugar E., Xiao W., Begum S., Viscidi R. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J. Natl. Cancer Inst. 2008, 6:407-420.
7. Goon P.K., Stanley M.A., Ebmeyer J., Steinsträsser L., Upile T., Jerjes W., Bernal-Sprekelsen M., Görner M., Sudhoff H.H. HPV & head and neck cancer: a descriptive update. Head Neck Oncol. 2009, 1:36-43.
8. Herrero R., Castellsagué X., Pawlita M., Lissowska J., Kee F., Balaram P., Rajkumar T., Sridhar H., Rose B., Pintos J., Fernández L., Idris A., Sánchez M.J., Nieto A., Talamini R., Tavani A., Bosch F.X., Reidel U., Snijders P.J., Meijer C.J., Viscidi R., Muñoz N., Franceschi S. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J. Natl. Cancer Inst. 2003, 95:1772-1783. IARC Multicenter Oral Cancer Study Group.
9. Kingma D.W., Allen R.A., Caughron S.K., Melby M., Moore W., Gillies B.M., Marlar R.A., Dunn T.S. Comparison of molecular methods for detection of HPV in oral and oropharyngeal squamous cell carcinoma. Diagn. Mol. Pathol. 2010, 19:218-223.
10. Kornegay J.R., Roger M., Davies P.O., Shepard A.P., Guerrero N.A., Lloveras B., Evans D., Coutlée F. International proficiency study of a consensus L1 PCR assay for the detection and typing of human papillomavirus DNA: evaluation of accuracy and intralaboratory and interlaboratory agreement. J. Clin. Microbiol. 2003, 41:1080-1086.
11. Kumar B., Cordell K.G., Lee J.S., Worden F.P., Prince M.E., Tran H.H., Wolf G.T., Urba S.G., Chepeha D.B., Teknos T.N., Eisbruch A., Tsien C.I., Taylor J.M., D'Silva N.J., Yang K., Kurnit D.M., Bauer J.A., Bradford C.R., Carey T.E. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J. Clin. Oncol. 2008, 26:3128-3137.
12. Machado J., Reis P.P., Zhang T., Simpson C., Xu W., Perez-Ordonez B., Goldstein D.P., Brown D.H., Gilbert R.W., Gullane P.J., Irish J.C., Kamel-Reid S. Low prevalence of human papillomavirus in oral cavity carcinomas. Head Neck Oncol. 2010, 2:1-6.
13. Sabol I., Salakova M., Smahelova J., Pawlita M., Schmitt M., Gašperov N.M., Grce M., Tachezy R. Evaluation of different techniques for identification of human papillomavirus types of low prevalence. J. Clin. Microbiol. 2008, 46:1606-1613.
14. Siriaunkgul S., Suwiwat S., Settakorn J., Khunamornpong S., Tungsinmunkong K., Boonthum A., Chaisuksunt V., Lekawanvijit S., Srisomboon J., Thorner P.S. HPV genotyping in cervical cancer in Northern Thailand: adapting the linear array HPV assay for use on paraffin-embedded tissue. Gynecol. Oncol. 2008, 108:555-560.
15. Smith E.M., Rubenstein L.M., Haugen T.H., Hamsikova E., Turek L.P. Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers. Cancer Causes Control 2010, 21:1369-1378.
16. Syrjänen S. Human papillomaviruses (HPV) in head and neck carcinomas. J. Clin. Virol. 2005, 32:S59-S66.
17. Tan S.E., Garland S.M., Rumbold A.R., Tabrizi S.N. Human papillomavirus genotyping using archival vulval dysplastic or neoplastic biopsy tissues: comparison between the INNO-LiPA and linear array assays. J. Clin. Microbiol. 2010, 48:1458-1460.
18. 10 line probe assay. J. Clin. Microbiol. 2002, 40:979-983.
19. van Doorn L.J., Molijn A., Kleter B., Quint W., Colau B. Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR. J. Clin. Microbiol. 2006, 44:3292-3298.
20. 10-INNO LiPA human papillomavirus (HPV) genotyping test and the Roche Linear Array HPV genotyping test. J. Clin. Microbiol. 2006, 44:3122-3129.
21. Weinberger P.M., Yu Z., Haffty B.G., Kowalski D., Harigopal M., Brandsma J., Sasaki C., Joe J., Camp R.L., Rimm D.L., Psyrri A. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J. Clin. Oncol. 2006, 24:736-747.
22. Weinberger P.M., Yu Z., Kountourakis P., Sasaki C., Haffty B.G., Kowalski D., Merkley M.A., Rimm D.L., Camp R.L., Psyrri A. Defining molecular phenotypes of human papillomavirus-associated oropharyngeal squamous cell carcinoma: validation of three-class hypothesis. Otolaryngol. Head Neck Surg. 2009, 141:382-389.
23. Wu Y., Chen Y., Li L., Yu G., Zhang Y., He Y. Associations of high-risk HPV types and viral load with cervical cancer in China. J. Clin. Virol. 2006, 35:264-269.